SAIC Frederick, Inc.
SAIC Frederick, Inc.
PROJECT |
AFFILIATION |
Mutant K-Ras Vaccines |
NCI |
|---|---|
F1-V Plague Vaccine, Milestone #1 |
NIAID |
rSEB Vaccine |
USAMRIID |
PA-83 (rPA) Vaccine |
USAMRIID/NIAID |
PROJECT |
AFFILIATION |
VEE Vaccine |
USAMRIID/JVAP/Dynport |
|---|---|
FGR Adenovirus Vaccine |
Henry Ford Health System |
AFP and GMCSF plasmids (2) and AFP Adenovirus Vaccines |
University of California, LA |
PROJECT |
AFFILIATION |
NGVL4a-CRT E7 Vaccine |
Johns Hopkins University |
|---|---|
PNGVL4pNGVL4a - Sig E7 (detox)/HSP70 |
Johns Hopkins University |
pING-TYRP2 plasmid Vaccine |
Memorial Sloan-Kettering |
pWRG 1644 DNA Plasmid Vaccine |
University of Wisconsin |
PROJECT |
AFFILIATION |
Pancreatic Tumor Cell Vaccines |
Johns Hopkins University |
|---|---|
EBV Supernatant Vaccine |
Johns Hopkins University |
Master Cell/Working Cell Bank for Allogeneic Vaccine |
Johns Hopkins University |
Phase I/II/III Id Vaccines for Lymphoma |
NCI |
PROJECT |
AFFILIATION |
PADRE-CMV Vaccine |
City of Hope Medical Center |
|---|---|
3 Vaccine Peptides for Breast Cancer |
Johns Hopkins University |
HPV 16 -- E7/MET-9-THR |
NCI |
PCLUS 3-18MN Peptide |
NCI |
PR103 (p53-194 His) Vaccine |
NCI |
PR24 (ras-12 Arg) |
NCI |
PR26a/p53-282-T-P |
NCI |
PR-81 Peptide |
NCI |
PR86/p53-196Pro Peptide |
NCI |
PR92 (p53-144Arg) |
NCI |
PR95 (p53-159Pro) |
NCI |
V166A-VHL14 |
NCI |
CAP-1 Peptide Vaccine |
NCI |
MART-1 Peptide Vaccine |
NCI |
HPV E7 Peptide Vaccine |
NCI |
Multiple patient specific peptide vaccines |
NCI |
Khleif Peptide Vaccines |
NCI |
Peptide Vaccine |
Thomas Jefferson University |
Bradykinin Antagonist Peptide |
University of Colorado Cancer Center |
EF-1 Peptide |
|
PXFK Peptide |
PROJECT |
AFFILIATION |
11B.11 Rat Anti Murine IL-4 |
NCI |
|---|---|
1D12 Anti-hu IgM |
NCI |
2A11 Anti Bombesin |
NCI |
3 Antibodies, Bu12-Saporin |
Simon Flavell Leukaemaia |
4KB128-Saporin, |
OKT10-Saporin Research Unit |
6D9 Anti ID |
NCI |
7G7 Anti-IL-2 alpha R |
NCI |
9.3 Anti CD2 for transplantation |
Navy Medical |
95-5-49 Anti T-cell |
NCI |
95-6-22 Anti T-cell |
NCI |
Anti CD45 MAB |
Vanderbilt University |
Anti-CD54 Monoclonal Antibody |
University of Texas |
B72.3 Anti Tag 72 |
University of Alabama, Birmingham |
BC8 |
Vanderbilt University |
C-225 (Chimerization) Anti EFGR |
University of California, San Diego |
Ch 14.18 Anti GD2 |
University of California, San Diego |
CH EB6 Anti-hu IgA |
NCI |
Ch R24 Anti GD3 |
Memorial Sloan Kettering |
Murine R24 Anti GD3 |
Memorial Sloan Kettering |
Murine E2.3 and A27.15 Anti Transferrin Receptor |
University of Arizona Health Science |
Chimeric 11-1F4 Anti ID for Leukemia |
University of Tennessee |
D612 Anti Colon Cancer |
University of Alabama, Birmingham |
HD37 |
University of Texas |
HeFi-1 |
NCI, Harvard Medical School |
HSV 863 |
NIAID |
Hu 14.18 IL-2 Fusion Protein |
University of Wisconsin |
Hu B3 |
NCI |
Hu HB22.7 |
University of California, Davis Cancer Center |
Hu Mik Beta 1 |
NCI |
huCC49-Delta-CH2 Anti Tag 72 |
NCI |
MRK-16 |
|
Mu B3 |
NCI |
Murine 225 Production Anti EFGR |
University of California, San Diego |
Murine 42/6 IgA Anti transferrin Receptor |
University of Arizona Health Science |
Murine 528 Anti EFGR |
University of California, San Diego |
Murine Anti Tac Anti IL-2R |
NCI |
OVB3 Anti-Ovarian Antibody |
NCI |
R24 Chimeric |
Memorial Sloan Kettering |
RFB4 |
University of Texas |
VH4-34 IgM216 |
Stanford University School of Medicine |
PROJECT |
AFFILIATION |
Wortmannin |
Arizona Cancer Center |
|---|---|
Fumagillin |
NCDDG |
Geldanamycin |
NCDDG |
Staurosporin |
NCDDG |
Endotoxin |
NCI |
PROJECT |
AFFILIATION |
MR1-1 DsFv-PE38 |
Duke University |
|---|---|
BL-22 (dsFv RFB4-PE38) for Lymphoma |
NCI |
ERB-38 |
NCI |
LMB-2 (Anti-TAC Fv PE-38) |
NCI |
HA-22 immunotoxin for Lymphoma |
NCI |
RN321-RFB4 Onconase |
NCI |
PROJECT |
AFFILIATION |
Hu IL-7 |
Boston University Hospital |
|---|---|
Recombinant Wollinella Asparaginase |
Indiana University |
Cyanovirin HIV Therapy |
NCI |
F-5 Cys Anti-Her2/neu scFv AB targeted Liposome |
University of California, San Francisco |
IL-4 Recertification |
NCI |
IL-6 Recertification |
Johns Hopkins University |
IL-2 Recertification |
NCI/Extramural |
PROJECT |
AFFILIATION |
KSR Antisense Oligonucleotide |
Memorial Sloan-Kettering |
|---|
PROJECT |
AFFILIATION |
Polio virus Chimera for Brain tumors |
Duke University |
|---|---|
Ad 3/5 Delta-24 |
Helsinki University |
Delta-24 Adenovirus Control |
M.D. Anderson |
Oncolytic Virus Delta-24-RGD for glioma and ovarian Cancer |
M.D. Anderson |
Herpes Vector Oncolytic Virus |
Harvard-Massachusetts General Hospital |
Ad5RGDTK/SSTRTK Oncolytic virus for Ovarian CA |
University of Alabama, Birmingham |
Tissue Specific CRAd: Ad Cox-2/RGD for Pancreatic Cancer |
University of Alabama, Birmingham |
Ad5RGDCD/SSTR Oncolytic Virus Head & Neck CA |
University of Alabama, Birmingham |
Ad-CCL-21 |
University of California, Los Angeles |
MV-NIS |
Mayo Clinic, Rochester, MN |
PROJECT |
AFFILIATION |
A549 Master Cell Bank |
BDP Resource |
|---|---|
Vaccinia Master/Virus Banks |
BDP Resource |
CHO Cell Bank |
BDP Resource |
MRC-5 CELLS |
BDP Resource |
NS/O Cells |
BDP Resource |
VERO CELL BANK |
BDP Resource |
HEK293 Master Cell Bank |
BDP Resource |
K562 Cells |
BDP Resource |
2E8 Cells |
SAIC-Frederick |
MVA Virus Bank |
BDP Resource |
T1165 Cells |
BDP Resource |
TF-1 Cells |
BDP Resource |
U87-MG cells |
BDP Resource |
DH5 Alpha E. Coli bank |
BDP Resource |
 |
 |
 |
 |
 |
|---|